Medtech Insight is part of the Business Intelligence Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

Tina Tan

Editor-in-Chief

London, UK
Since she began covering the medtech industry in the late 1990s, Tina Tan has seen significant changes in the industry landscape: companies bulking up to become sector heavyweights, unwieldy conglomerates restructuring to get leaner, new players with game-changing technologies growing and thriving, struggling firms sadly fizzling into oblivion. She has also witnessed how the ever-evolving healthcare environment has impacted the way medical device companies operate, inciting them to develop new technologies – and services – to meet the needs of patient, physician and, of courses, the healthcare payer. As Editor, and prior to that Business Editor, of Clinica Medtech Intelligence, it is Tina’s experience and understanding of the key issues affecting medical device companies that has enabled her to maintain the high quality, business-critical content of Clinica for which the product is recognized globally. Tina has also dabbled in other sectors outside of medtech, having written for an eyewear fashion and an alternative health publication. But as attractive as it was to get cost-price Armani frames and free samples of organic root vegetables, Tina found herself being drawn back to the excitement of the medtech sector. Like many of her long-time colleagues covering this beat, she still marvels at the incredible gizmos and gadgets that are coming out from the industry, especially from the start-ups, and the genius creativity behind these potentially life-saving technologies.  
Advertisement
Set Alert for Articles By Tina Tan

Latest From Tina Tan

ReCor Deal Underscores RDN Revival – But Also Reason For Backing Medtech?

Certain VCs are becoming reluctant to invest in medtech, citing difficulties such as a shrinking pool of buyers and increasing regulatory challenges. But Sofinnova Partners has successfully sold a medical device portfolio company – and one that is in a difficult field like renal denervation, no less – to a Japanese buyer. Antoine Papiernik, managing partner at the French VC, explains how persevering with a renal denervation technology paid-off and gives his perspective on whether medtech is still a space worth investing in.

Commercial Deals

Medtech Money Flow: Weekly M&A And VC Deals, July 9-15, 2018

In this weekly feature, Medtech Insight presents a roundup of the previous week's M&A deals and venture financing rounds recorded in our M&A and VC Deal Trackers. This edition presents the transactions announced July 9-15, 2018.
M & A Financing

VC Deals Analysis: Mega-Rounds Abound, As H1 Deal Value Rockets Past $4Bn

A quartet of mega-rounds in June closed off what has been the most successful first-half since 2014, with an impressive $4.7bn of private venture funds raised in total. Digital health is one area that is evidently rising in investor popularity and potentially helping to drive these mega-rounds.

Deals Financing

Medtech Money Flow: Weekly M&A And VC Deals, July 2-8, 2018

In this weekly feature, Medtech Insight presents a roundup of the previous week's M&A deals and venture financing rounds recorded in our M&A and VC Deal Trackers. This edition presents the transactions announced July 2-8, 2018.

Deals M & A

SAV-IOL Seeks Investors To Sharpen Presbyopia Focus With Smart IOL

Swiss Advanced Vision is extending its expertise in intraocular lenses to develop a new line of smart IOLs that automatically focus in real-time to correct presbyopia. These active lenses will also have a remote calibration feature so they can easily be adjusted post-implantation.

Ophthalmology Innovation

Exec Chat: BD's Head Of Diagnostic Systems On Taking The Long View For Bigger Wins

In the face of BD’s (Becton Dickinson & Co.) ever-broadening portfolio – bulked up by the group's appetite for billion-dollar acquisitions – the Diagnostic Systems unit remains an important, and currently the strongest, contributor to BD's overall growth story. Dave Hickey, worldwide president of BD Diagnostic Systems, spoke to Medtech Insight about the trends that are driving, as well as limiting, the in vitro diagnostics sector, and how BD is addressing those issues to keep the business's top-line buoyant.

In Vitro Diagnostics Business Strategies
See All
Advertisement
UsernamePublicRestriction

Register